399 related articles for article (PubMed ID: 26363571)
1. Incidence and Risk Factors for Postcontrast Acute Kidney Injury in Survivors of Sudden Cardiac Arrest.
Petek BJ; Bravo PE; Kim F; de Boer IH; Kudenchuk PJ; Shuman WP; Gunn ML; Carlbom DJ; Gill EA; Maynard C; Branch KR
Ann Emerg Med; 2016 Apr; 67(4):469-476.e1. PubMed ID: 26363571
[TBL] [Abstract][Full Text] [Related]
2. [Acute kidney injury and renal replacement therapy in victims from out-of-hospital cardiac arrest with administration of contrast agent].
Christ M; Auenmüller KI; Amirie S; Brand M; Sasko BM; Trappe HJ
Herzschrittmacherther Elektrophysiol; 2016 Mar; 27(1):6-14. PubMed ID: 26671252
[TBL] [Abstract][Full Text] [Related]
3. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
[TBL] [Abstract][Full Text] [Related]
4. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
5. The use of gadolinium for arterial interventions.
Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC
Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688
[TBL] [Abstract][Full Text] [Related]
6. The Preinterventional Cystatin-Creatinine-Ratio: A Prognostic Marker for Contrast Medium-Induced Acute Kidney Injury and Long-Term All-Cause Mortality.
Lüders F; Meyborg M; Malyar N; Reinecke H
Nephron; 2015; 131(1):59-65. PubMed ID: 26287495
[TBL] [Abstract][Full Text] [Related]
7. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C and contrast-induced acute kidney injury.
Briguori C; Visconti G; Rivera NV; Focaccio A; Golia B; Giannone R; Castaldo D; De Micco F; Ricciardelli B; Colombo A
Circulation; 2010 May; 121(19):2117-22. PubMed ID: 20439784
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
10. Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial.
Timal RJ; Kooiman J; Sijpkens YWJ; de Vries JPM; Verberk-Jonkers IJAM; Brulez HFH; van Buren M; van der Molen AJ; Cannegieter SC; Putter H; van den Hout WB; Jukema JW; Rabelink TJ; Huisman MV
JAMA Intern Med; 2020 Apr; 180(4):533-541. PubMed ID: 32065601
[TBL] [Abstract][Full Text] [Related]
11. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).
Er F; Nia AM; Dopp H; Hellmich M; Dahlem KM; Caglayan E; Kubacki T; Benzing T; Erdmann E; Burst V; Gassanov N
Circulation; 2012 Jul; 126(3):296-303. PubMed ID: 22735306
[TBL] [Abstract][Full Text] [Related]
12. Posttraumatic contrast-induced acute kidney injury: minimal consequences or significant threat?
Matsushima K; Peng M; Schaefer EW; Pruitt JH; Kashuk JL; Frankel HL
J Trauma; 2011 Feb; 70(2):415-9; discussion 419-20. PubMed ID: 21307743
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
Brar SS; Aharonian V; Mansukhani P; Moore N; Shen AY; Jorgensen M; Dua A; Short L; Kane K
Lancet; 2014 May; 383(9931):1814-23. PubMed ID: 24856027
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
McCullough PA; Williams FJ; Stivers DN; Cannon L; Dixon S; Alexander P; Runyan D; David S
Am J Nephrol; 2012; 35(6):509-14. PubMed ID: 22627273
[TBL] [Abstract][Full Text] [Related]
15. Postcontrast Acute Kidney Injury in Pediatric Patients: A Cohort Study.
McDonald JS; McDonald RJ; Tran CL; Kolbe AB; Williamson EE; Kallmes DF
Am J Kidney Dis; 2018 Dec; 72(6):811-818. PubMed ID: 30041876
[TBL] [Abstract][Full Text] [Related]
16. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
17. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
18. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
[TBL] [Abstract][Full Text] [Related]
20. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
